Earlier this year, the FDA approved 2 new indications for Aquaflor. According to Merck, the supplemental approval increased ...
FDA clearance of HG202 marks a significant milestone for CRISPR ... The BRIGHT trial is a phase 1, open-label, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback